Beyond Inhibition: Emerging Approaches in Ubiquitin–Proteasome‐Mediated Protein Degradation for Precision Targeting
Targeted protein degradation (TPD) represents an emerging paradigm in drug discovery, capable of overcoming the limitations of traditional therapeutic strategies based on protein inhibition. Exploiting the ubiquitin–proteasome system (UPS), TPD allows the selective elimination of pathologically relevant proteins. The m...